As an important nuclear hormone receptor, estrogen receptor a (ERa), which is encoded by the Esr1 gene, regulates the expression of hundreds of genes in a stimulus-specific, temporal, and tissuespecific fashion, mainly by binding to specific DNA sequences called estrogen response elements (EREs). As an important estrogen target tissue in males, the function of the efferent ductules relies on the presence of the ERa protein, but the underlying regulatory mechanisms are poorly illustrated. In this study, genome-wide ERa-binding sites in mouse efferent ductules were mapped by chromatin immunoprecipitation sequencing. In total, 12,105 peaks were identified, and a majority of them were located far from the annotated gene transcription start site. Motif analysis revealed that ;80% of the ERa-binding peaks harbored at least one ERE, whereas androgen response element-like sequences were the most overrepresented motif in the peaks without any EREs. A number of candidate transcription factor motifs adjacent to the EREs were significantly enriched, including AP2 and GRE, implying the involvement of these putative adjacent factors in the global regulation of ERa target genes. Unexpectedly, more than 50% of the ERa-binding peaks in mouse efferent ductules overlapped with those binding peaks previously identified in mouse uterus, suggesting the conserved mechanism of ERa action in these two tissues. Cobinding of ERa target genes by androgen receptor was further confirmed for Slc9a3 gene, which was responsible for fluid resorption in the efferent ductules. Taken together, our study provides a useful reference set for future work aimed at exploring the mechanism of ERa action in physiological conditions. (Endocrinology 158: 3724-3737, 2017) A s important steroid hormones, estrogens exhibit a broad spectrum of physiological functions in various target tissues, including the reproductive, central nervous, bone, and cardiovascular systems as well as in normal mammary gland development (1, 2). In the classical mechanism of estrogen action, its effect is mediated mainly by two receptors, estrogen receptor a (ERa) and estrogen receptor b, which exert their functions in a ligand-dependent manner. Upon the binding of estrogens to their receptors, ligand-specific conformational changes of the receptors are induced. The ligand-bound receptors dissociate with heat shock proteins, dimerize, and bind to DNA containing sequence-specific response elements known as estrogen response elements (EREs) through their zinc finger-containing DNA-binding domain. Then, a coactivator or corepressor complex, which
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Identification of estrogen target genes is essential for fully elucidating the functions and mechanisms of their action. To achieve this goal, many gene expression profiling studies were performed and hundreds of target genes were identified (5) (6) (7) (8) (9) (10) . However, these RNAsequencing and microarray assays cannot discriminate the direct target genes from the indirect and secondary target genes. Recently, chromatin immunoprecipitation (ChIP) followed by microarray or massively parallel sequencing (ChIP-seq) has been used to map genome-wide ERa-binding sites in breast cancer cell lines, and tens of thousands of binding regions have been identified (11) (12) (13) (14) (15) (16) . In addition to the numerous elegant works in breast cancer cell lines, some investigations were also conducted on the intact chromatin from estrogen target tissue samples. Gao et al. (17) applied the ChIP followed by microarray approach to scan for ERa-binding sites in a mouse liver treated with an estradiol injection for 2 hours, and 5568 ERa-binding regions were identified. Many ERa-bound genes correlated with the metabolism process were uncovered. Hewitt et al. (9) compared the ERa-binding profiles in the ovariectomized uterine tissue of mice supplemented for 1 hour with saline vehicle or E2; 5184 and 17,240 peaks were identified, respectively. ERa binding to the genome in the absence of ligand and its association with the HOX protein family was emphasized. The tissue-specific binding profiles of ERa were also recently reported by directly comparing the ERa cistromes in the mouse aorta and liver (8) .
All of the ERa-binding sites identified were studied in the estrogen target tissues of female mice, whereas ERa also plays an essential role in males, especially in the efferent ductules that are the indispensable parts of the male reproductive tract. As an important estrogen target tissues in males, the efferent ductules have the following features: (1) they contain the highest level of ERa in any organs examined to date, and the ERa messenger RNA level is ;3.5-fold greater than that in the uterus (18); (2) the estrogen level in rete testis fluids is even higher than the average level in female serum (19) ; and (3) the efferent ductules function to reabsorb more than 90% of the fluids secreted by the testis, but this function is disrupted when the Esr1 gene is deleted from the genome and finally leads to male infertility (20) (21) (22) (23) (24) , although other mechanisms might also contribute to the phenotype. The dysregulation of several individual genes, such as Aqp1, Slc9a3, and CaII, is responsible for the accumulation of fluid in the efferent ductules of aERKO mice (25, 26) , and the global transcripts regulated by E2 have also been identified by a microarray analysis (10) . However, with regard to the aromatase gene Cyp19a1, which can convert androgen to estrogen, the knockout mice did not mimic the phenotype of the aERKO mice (27, 28) . This indicates that the mechanism of ERa regulation in the efferent ductules is extremely complicated and that the E2-regulated transcriptome is obviously not enough to fully illustrate the mechanism of ERa action in the efferent ductules. Thus, the ERa cistrome in the efferent ductules may shed light on the problem. To comprehensively evaluate the genome-wide interaction between ERa and its target genes, we conducted a ChIPseq analysis of the ERa-binding sites in the efferent ductules in physiological conditions. This report describes the ERa cistrome in male mice in physiological conditions.
Materials and Methods

Animals
Male C57BL/6 mice were purchased from the Animal Center of the Chinese Academy of Sciences (Shanghai, China). The experiments were conducted according to a protocol approved by the Institute Animal Care Committee. The protocol conformed to internationally accepted guidelines for the humane care and use of laboratory animals.
ChIP
ChIP was performed as previously described (29, 30) , with some noteworthy changes. Efferent ductules were dissected from 20 adult male mice at 8 to 10 weeks of age and minced into ;1-mm 3 pieces with a razorblade in ice-cold phosphatebuffered saline (PBS). After washing twice with ice-cold PBS to remove the lumen fluid and sperm, the tissue pieces were crosslinked in 1% formaldehyde at room temperature for 12 minutes. The tissue pieces were then pelleted, rinsed, and resuspended in PBS containing protease inhibitors and were disaggregated on ice using a glass homogenizer. The nuclei were filtered, collected, and resuspended in lysis buffer (1% sodium dodecyl sulfate (SDS), 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, 13 protease inhibitor cocktail, and 1 mM phenylmethanesulfonyl fluoride) on ice for 10 minutes and sonicated to yield 200-to 300-bp DNA fragments. After centrifuging for 10 minutes, supernatants were collected and precleared with Protein A agarose beads (sc-2001, Santa Cruz Biotechnology, Santa Cruz, CA) at 4°C for 2 hours. After centrifugation, 30 mL of the supernatant was used as the input; the remainder was diluted twofold in dilution buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, and 20 mM Tris-HCl, pH 8.1) and was subjected to immunoprecipitation overnight at 4°C with 4 mg of a specific antibody. After a 2-hour incubation with Protein A agarose beads, the chromatin-antibody-bead complexes were washed sequentially twice with Tris/sucrose/EDTA I buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, and 150 mM NaCl), twice with Tris/sucrose/EDTA II buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1, and 500 mM NaCl), twice with buffer III (0.25 M LiCl, 1% Nonidet P-40, 1% deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl, pH 8.1), and twice with a fourth buffer (1 mM EDTA and 10 mM Tris-HCl, pH 8.1). Chromatin was eluted with elution buffer (1% SDS and 0.1 M NaHCO 3 ) before reversing the cross-links with Proteinase K (Invitrogen, Carlsbad, CA) at 65°C for at least 8 hours. DNA was purified using phenol-chloroform extraction and ethanol precipitation and then resolved in an optimal volume of double-distilled H 2 O. The following Santa Cruz antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) were used for ChIP: anti-ERa [MC-20; sc-542, research resource identifier (RRID): AB_631470] and anti-AR (H-280; sc-13062, RRID: AB_633881).
ChIP-seq
The ChIPs were performed with an anti-ERa antibody as described previously. The sequencing sample preparation was performed as described by following the Illumina ChIP-Seq DNA Sample Prep Kit (Illumina Inc., San Diego, CA) protocol. Briefly, the DNA ends were polished and were 5 0 -phosphorylated using T4 DNA polymerase, Klenow polymerase, and T4 polynucleotide kinase. After the addition of the 3 0 -A to the ends using the Klenow fragment (3 0 -5 0 exo minus), the Illumina genomic adapters were ligated and the sample was size fractionated on a 2% agarose gel. After cluster generation, 49 cycles of sequencing were performed on the Illumina Genome Analyzer II following the manufacturer's instructions. The sequencing data were processed using the Genome Analyzer Pipeline Software. The sequenced tags were mapped to the mouse genome mm9 using the Eland program allowing for, at the most, two mismatches, and the resulting Eland multifiles were subjected to peak finding.
Peak finding
The ERa-binding peaks were identified with a relevant overrepresentation of tags in the ERa ChIP sample compared with input sample using MACS (31, 32) with the default parameters. Peaks with a P value cutoff of 1.00e-05 and an enrichment greater than fourfold were chosen for the analysis.
ChIP-PCR and ChIP-qPCR
The ChIP assays were performed on mouse efferent ductules as described previously. The primers were designed to amplify a 70-to 200-bp region around the peak summit. The ChIPed DNAs were analyzed by PCR or qPCR using the SYBR Green master mix (TOYOBO, Osaka, Japan). The primers are listed in Supplemental Table 1 .
Motif search
The motif search was performed as previously described (29) . Briefly, 200-bp sequences surrounding each peak summit of the top, medium, and low 300 peaks were extracted for the de novo motif search. MEME (33) was applied using the default parameters to identify the statistically overrepresented motifs. The ERa peaks were uniformly resized to 500 bp centered on the peak summit. These sequences were scanned for transcription factor motifs with the RegionMiner subtask: overrepresented transcription factor-binding sites (TFBSs) or modules (Genomatix Software GmbH, http://www.genomatix.de/). The task searches for all of the relevant TFBS within the input sequences and generates statistics on the TFBS and modules (pairs of TFBS within 10-to 50-bp distance) together with the overrepresentation values and z scores. Sequence logos for specific transcription factor families were constructed using Weblogo (34) . Binding sites without EREs were analyzed by MEME-ChIP (35) to identify the potential transcription factors directing ERa to specific genomic loci through the tethering pathway.
Coimmunoprecipitation
The efferent ductules were dissected from adult male mice and were homogenized in radioimmunoprecipitation assay (RIPA) lysis buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100] supplemented with 13 protease inhibitor cocktail (Roche, Mannheim, Germany) and 1 mM phenylmethanesulfonyl fluoride. After lysis at 4°C for 30 minutes and centrifugation at 4°C for 10 minutes, the protein concentration of the supernatant was determined by the BCA protein assay kit (Pierce, Rockford, IL) and was adjusted to 5 mg/mL with RIPA buffer, and 4 mg of the anti-ERa antibody and the normal rabbit mL G were added to 500 mL of the protein extracts for immunoprecipitation at 4°C overnight. After incubation with 50 mL of protein A agarose beads (Santa Cruz Biotechnology) at 4°C for 2 hours, the resin was washed three times at 4°C by adding 500 mL of RIPA buffer. Finally, 40 mL of 13 SDS loading buffer was added to the beads, and the samples were boiled at 99°C for 5 minutes for western blot analysis using the anti-AR antibody.
Luciferase reporter assay
Approximately 500-bp sequences around the peak summit of the Slc9a3 gene were subcloned into pGL3-TATA luciferase reporter vectors. HEK293T cells were grown in 96-well plates and were cotransfected with 70 ng of reporter constructs, 10 ng of pRL-TK, and 10 ng of the pcDNA3.1-AR and/or pcDNA3.1-ERa expression vector coding for full-length human AR or ERa using the FuGENE HD Transfection Reagent (Roche). The blank pcDNA3.1 vector was added to balance the quantity of the total transfected DNA if the pcDNA3.1-AR or pcDNA3.1-ERa expression vector was absent. Six hours after the transfection, the cells were treated with 100 nM DHT, 100 nM E2, or ethanol vehicle for 24 hours. The luciferase activity was measured using the dual-luciferase reporter assay (Promega, Madison, WI) and BioTek Synergy NEO Multi-Mode Reader. The primer sequences are listed in Supplemental Table 2 .
Results
Genome-wide identification of ERa genome-binding regions in mouse efferent ductules
Because mouse efferent ductules are very tiny and nearly transparent tissues embedded in the epididymal fat pad, it is extremely difficult to specifically isolate these tissues without adipocyte contamination. The representative photographs of the mouse efferent ductules before and after removing of the epididymal fat pad are given in Supplemental Fig. 1(a) and 1(b) to show the typical morphology of the mouse efferent ductules. Additionally, levels of Slc9a3 and Aqp9 that were expressed in the efferent ductules and fat-specific genes Adipoq and Fabp4 were detected by reverse transcription quantitative polymerase chain reaction (qPCR); the results indicated that the tissues we dissected were indeed the efferent ductules with very limited adipocyte contamination [Supplemental Fig. 1(c) and 1(d) ]. As with all immunoprecipitation experiments, the antibody is very important for a successful ChIP experiment; thus, the specificity of the antibody used in our ChIP-seq study was tested by a western blot analysis [Supplemental Fig. 2(a) ]. Then, ChIP was performed on the efferent ductules from adult male mice. After evaluating the ChIP efficiency by ChIP-qPCR [Supplemental Fig. 2(b) ], the ChIPed DNA and control input DNA were subjected to next-generation high-throughput sequencing and the resulting 49 base pair (bp) sequence reads were aligned to the National Center for Biotechnology Information (NCBI) mouse genome database (NCBI Build 37/mm9). A global analysis of the ChIP-seq data identified 12,105 peaks using the model-based analysis of ChIP-seq (MACS; http://liulab.dfci.harvard.edu/macs/) algorithm with a P # 1.00e-5 (Table 1) ; a complete list of the peaks is provided in Supplemental Table 3 . To validate our ChIP-seq results, the enrichment of randomly selected peaks with various fold enrichment was confirmed by an individual ChIP combined with conventional PCR. Of these, 24 of the 25 (96%) were validated in the efferent ductules (Supplemental Fig. 3 ), suggesting that our ChIP-seq data were reliable and that the deduced peaks represented bona fide in vivo ERa-binding sites.
The peaks were mapped to reference genes of NCBI Build 37/mm9, and the peak distribution relative to the genomic boundaries was analyzed using the Webbased application Cistrome (36) . The results indicated that the majority of the ERa-binding sites were located within intergenic regions .10 kb from an annotated gene (32.3%) and introns (43.4%) [ Fig. 1(a) ]. Although only 3.6% of the ERa-binding sites were located within 1 kb upstream of the transcription start site (TSS), there was a more than threefold enrichment compared with the genome background (3.6% vs 1.1%) (Supplemental Fig. 4) . A further analysis of the relative distribution of the ERa-binding sites resulted in a sharp peak at the TSS with a large percentage of binding sites within 20 kb of the TSS [ Fig. 1(b) ]. Most of the intronic ERa-binding sites were closer to the target gene TSS, with 4009 binding regions within the first intron [ Fig. 1(c) ]. Exonic ERabinding events typically occurred at the beginning of the coding region [ Fig. 1(c) ]. A total of 7874 reference sequence genes (NCBI reference sequences) were defined as peak-associated genes by the Stanford Genomic Regions Enrichment of Annotations (GREAT) algorithm.
Identification of EREs
To uncover possible alternative ERa-binding motifs, the peaks were ranked by fold enrichment, and a de novo motif discovery algorithm, Multiple Expectation Maximization for Motif Elicitation (MEME, http://meme-suite.org), was performed on the top, medium, and low 300 peaks. The ERE motif (A/G) GGTCANNNTGACC(T/C), which is similar to the established consensus canonical ERE, was most represented regardless of the enrichment levels of the input peaks. However, the motif similarity to the consensus ERE was reduced following the decrease of the fold enrichment of the selected peaks [ Fig. 2(a) ].
To investigate whether the ERa-binding sites were enriched in the consensus EREs, Genomatix RegionMiner, release 3.2 (http://www.genomatix.de/index. html), was used to map the potential ERa-binding sites among the 170 vertebrate transcription factor matrix families represented in the MatBase matrix library. As expected, the ERE motif was the most overrepresented motif by fold enrichment and z score. In total, 79.7% (9653 of 12,105) of the ERa-binding peaks contained EREs (Supplemental Table 4 ). Among these, .50% contained two or more EREs [ Fig. 2(b) ]. The peaks that were absent a canonical ERE were mainly those with an enrichment fold below 25, which represented a low-affinity binding [ Fig. 2(c)] . A de novo motif analysis of the ERa-binding peaks without EREs using MEME-ChIP showed that a motif sequence very similar to the half-site-like androgen response element (ARE) was the most represented motif, indicating that the androgen receptor might facilitate ERa binding to its target sites without an ERE [ Fig.  2(d)] . Moreover, the coimmunoprecipitation (co-IP) assay further implied that ERa and androgen receptor (AR) might interact with each other in mouse efferent ductules [ Fig. 2(e) ].
Other transcription factor-binding motifs associated with EREs
To uncover possible coregulatory networks between ERa and other transcription factors in the efferent ductules, RegionMiner was used to identify the most Table 4 ). These top five transcription factor motif sequences were constructed using Weblogo (http://weblogo.berkeley.edu/), and the resulting motifs closely resembled the motifs represented in the MatBase database [ Fig. 3(a) ]. For further analysis, overrepresentation analysis of the modules [i.e., pairs of transcription factor-binding sites within 10 to 50 bp (middle to middle)], was performed using RegionMiner in which the ERE was the designated partner. Of note, the ERE-GRE module was the most overrepresented, with a z score of 185.7, which indicated a possible coregulatory effect of their target genes between ERa and AR [ Fig. 3(b) ]. To validate whether AR was corecruited to the ERa-binding regions, ChIP was performed using an antibody for AR, and the enrichment of 11 randomly selected ERa-binding regions that were validated (Supplemental Fig. 3 ) was determined by realtime PCR. As shown in [ Fig. 3(c) ], 5 of 11 (45.5%) of the randomly selected regions were significantly enriched compared with the negative control, providing evidence that AR might act together with ERa in target gene regulation in mouse efferent ductules. 
Integration of the binding sites and gene expression data
To understand the biological meaning of the ERabinding events, the Stanford GREAT tool, which comprehensively interprets the functions of cisregulatory regions, was used to assign peaks to the nearby annotated genes (37) . A total of 7874 annotated genes were associated with ERa peaks. Gene Ontology analysis showed that these genes were mainly involved in cell junction and organization and regulation of the generation of precursor metabolites and energy, sequence-specific DNA binding transcription factor activity, cellular carbohydrate catabolic process, and endosome transport, which represented the general and tissue-specific functions of ERa. A complete list of the enriched biological processes is provided in Supplemental Table 5 .
To examine the correlation of ERa-binding regions in the efferent ductules with the transcriptional regulation of neighboring genes, we compared the ERa peaks in the De novo search for enriched motifs within the ERa-binding peaks without a consensus ERE using MEME-ChIP revealed that the consensus ARE half-site was the most overrepresented motif. The upper panel represents the consensus ARE; the lower panel represents the ARE half-site overrepresented within the ERa-binding peaks without a consensus ERE. (e) Coimmunoprecipitation of ERa and AR in mouse efferent ductules indicated that ERa interacts with AR under physiological conditions. Protein was extracted by RIPA and was immunoprecipitated with an ERa antibody or normal rabbit immunoglobulin G (IgG) overnight at 4°C. The eluate was subjected to western blot analysis and was detected by an AR antibody.
efferent ductules with E2 differentially regulated transcripts from the microarray datasets previously described by Elizabeth and colleagues (10) . In total, 605 of 1407 (43.0%) E2 upregulated genes and 375 of 952 (39.4%) E2 downregulated genes harbored at least one ERa-binding region. A complete list of E2-regulated genes harboring at least one ERa-binding peaks is provided in Supplemental Table 6 .
These genes include a large number of solute carrier family members, which are essential for transporting small molecules and are involved in the efferent ductules reabsorption function [ Fig. 4(a) ]. Interestingly, most of the aquaporin genes were also bound by ERa in mouse efferent ductules regardless of their regulation by E2. Aqp1, although its reduction in protein level in aERKO mice Table 4 . (b) Distribution of the GRE, ERE, RXR, NR2, NF1, and AP1 motifs within 10-to 50-bp relative to the EREs in the ERa-binding peaks. (c) Detection of AR occupancy at the ERa-binding regions by ChIP-qPCR. NC, negative control. The data are presented as the mean 6 standard deviation of three replicates. *P , 0.05, **P , 0.01, ***P , 0.001. The peak associated genes and primers for Fig. 3(c) are listed in Supplemental Table 1. was postulated to be secondary to the morphological defects of the efferent ductules epithelium, was bound by ERa in its exon 2, 3 0 untranslated region, and ;10 kb downstream of its transcription termination site. Aqp5, another aquaporin gene regulated by E2, as shown by the microarray study, was bound by ERa perfectly at its promoter, explaining the mechanism of its regulation by E2 in the efferent ductules [ Fig. 4(b) ]. It has been reported that Aqp5 is present in the adipocytes and absent in the efferent ductules (38, 39) and that the epididymal fat pad is estrogen responsive (40) . To rule out the possibility that the ERa-binding peaks present in the Aqp5 promoter region is the result of the epididymal fat pad contamination, ChIP-qPCR was performed on both the efferent ductules and the epididymal fat pad. The result showed that ERa specifically bound to the Aqp5 promoter in the efferent ductules but not in the epididymal fat pad [ Fig. 4(c) ], which further confirmed the specificity for our tissue dissection.
Overlap with uterus ChIP-seq analysis
Hewitt et al. (9) previously mapped the ERa-binding regions in mouse uterus, and their datasets were extracted from the Gene Expression Omnibus database. Peak calling was performed by MACS with the same parameters as the efferent ductules, and 13,988 and 50,215 peaks were identified in the vehicle-and E2-treated uterus, respectively. Next, we compared the ERa-binding regions in these two important estrogen target tissues. Surprisingly, 55.1% (6665 of 12,105) of the ERa-binding regions in the efferERa-binding regions in the E2-treated uterus. In addition, 73.8% (4916 of 6665) of the overlapping peaks were associated with E2-induced binding events in the uterus [ Fig. 5(a) ]. A transcription factor motif discovery analysis by RegionMiner showed that GRE, which represented the AR-binding sequences, was the most overrepresented motif in the efferent ductule-specific peaks but not in the peaks shared by the efferent ductules and the uterus [ Fig. 5(b) ]. When GREAT was used to assign these peaks to nearby annotated genes, 5613 and 5282 genes were associated with the efferent ductules and uterus overlapping peaks and the efferent ductulespecific peaks, respectively. Gene ontology analysis showed that similar biological processes were enriched by these genes; however, the processes "endosome transport" and "response to osmotic stress" were exclusively and significantly enriched in the genes associated with the efferent ductule-specific peaks, which was in line with the function of ERa in the efferent ductules as indicated by the phenotype of aERKO mice [ Fig. 5 (c) and
Coregulation of Slc9a3 by ERa and AR As an Na + /H + exchanger, SLC9A3 plays an important role in lumen fluid reabsorption in efferent ductules (26) and is postulated to be dual regulated by ERa and AR (10, 25, 41, 42) . Although the presence of a palindromic ERE and an additional consensus ERE half-site inspires the expectation that ERa may directly regulate Slc9a3 expression, no experimental evidence has confirmed that ERa binds to Slc9a3 gene regulatory sequences in vivo. In our current study, five ERa-binding sites were Table 5 .
exclusively identified in mouse efferent ductules but not in mouse uterus [ Fig. 6(a) ], and four of them were validated by ChIP-qPCR to be bound by both ERa and AR [ Fig. 6 (b) and 6(c)]. Although peak 1 had the highest tag intensity in our ChIP-seq analysis, the sequences around peaks 2, 3, and 4, which were more adjacent to the Slc9a3 gene promoter, stimulated reporter gene transcription in response of dihydrotestosterone (DHT) treatment in a luciferase assay [ Fig. 6(d) ], and this activity was blocked by the ERa protein but not by E2 [ Fig. 6(e) ]. Additionally, the ERa protein also inhibited the stimulating effect on the prostate specific antigen enhancer containing positive control vector, which was in accordance with the previously report that AR and ERa mutually inhibited each other's transcriptional activity by directly protein interactions [ Fig. 6(d) ] (43). These results demonstrate that ERa associates with AR to keep an appropriate stimulation of Slc9a3 gene expression by androgens.
Discussion
Until complete infertility in male mice lacking ERa was reported more than two decades ago, estrogens were thought to be of little importance in male fertility. Although further studies demonstrated that the infertility of aERKO mice was primarily caused by the severe disruption of reabsorption activities of the efferent ductules, what we knew about the molecular mechanisms underlying it was very limited. A previous study using a castration and estradiol replacement mouse model found more than 2000 estrogen-regulated genes (10), but this model had the following drawbacks: (1) the ERa protein level was downregulated by the excessive estrogens in the efferent ductules (44); (2) some genes playing important roles in efferent ductules might be regulated by ERa via estrogen independent manner (45, 46) ; and (3) the model cannot discriminate the direct or indirect target genes of estrogens. Another study attempted to uncover ERa-and AR-regulated genes by combining proteome analysis and genomewide computational prediction of conserved ARE and ERE, but the protein identified in the efferent ductules is very limited (41). What's more, ERa and AR binding to their cognate responsive elements is context specific and only a small proportion of AREs/EREs could be bound in specific conditions, so the presence of conserved AREs/EREs in the gene promoters cannot actually represent ERa and AR binding at these sites. Therefore, to further clarify the molecular mechanism, in the current study, we mapped the genome-wide ERa-binding sites using ChIP-seq technology to identify the genome-wide ERa-binding sites in male tissue under physiological conditions. Compared with previous genome-wide studies on ERa-binding sites in human breast cancer cell lines and mouse tissues, such as the uterus, aorta, and liver, our study provided insights into the canonical estrogen pathway. First, a previous ERa ChIP-seq study in mouse uterus revealed that only 10% to 20% of the binding sites were located within 10 kb of the annotated RefSeq TSS, whereas 75% of the binding sites in our previous AR ChIP-seq study in mouse caput epididymis were more proximal to the TSS (29) . Those authors speculated that this difference might be due to the duration time that the samples were exposed to the steroid hormones. That only 37.5% of the binding sites were within 20 kb of the TSS in our homeostatic state of continuous exposure to endogenous estradiol obviously did not support this hypothesis. Instead, our result suggested that ERa might prefer to regulate target gene expression by interacting with the distal enhancer compared with the proximal promoter used by AR. Second, when the ERa-binding sites in the efferent ductules and the uterus were compared, ;55% of the binding sites in the efferent ductules overlapped with those in the uterus, although they were the popular target tissues in the different sexes. Interestingly, a recent report comparing the ERa-binding sites among different mouse tissues showed that the overlapping peaks between the uterus and liver or aorta were ,20%, which was much lower than the proportion between the efferent ductules and uterus. This result indicated that ERa might play a more conserved role between the male and female reproductive systems than different target tissues of the same sex. Third, that only 15.66% (15 of 83) of the efferent ductules expressing genes with conserved ERE(s) identified by proteomics and computational prediction as mentioned above overlapped with our peak-associated genes further demonstrated that the power of computational prediction of the in vivo ERa-binding sites was very limited.
The canonical pathway of ERa relies on recognition and interaction with the EREs interspersed across the genome. Motif scanning around the peak summit of our ERa-binding sites in the efferent ductules revealed that ;80% of the ERa peaks contained at least one ERE, and a de novo motif discovery using peaks with a diverse enrichment fold also found that the ERE was the most overrepresented motif. These results indicated that ERa bound to its target sites mainly through direct interaction with its response element. However, there were still ;20% of peaks without any EREs, which might represent the noncanonical tethering mechanism through an interaction with other transcription factors, such as the previously reported SP1 (47) and AP1 (48). As a pioneer protein, FOXA1 interacts with closed nucleosome arrays, creating an accessible chromatin site for ERa binding to its cognate response elements (49) . Until now, numerous studies have confirmed the association of FOXA1 and ERa in breast cancer (12, (50) (51) (52) , hepatocarcinoma (53) , and endometrial carcinomas (54) . However, in our ChIP-seq study of ERa in mouse efferent ductules, although as many as ;200 transcription factor motifs were significantly enriched compared with their frequency in the genome, the FOX transcription factor family was not enriched at all. CEAS, another algorithm for DNA motif discovery, could not find the FOX binding motif either. In addition, the messenger RNA and protein levels of Foxa1 were almost undetectable in the efferent ductules compared with those in the stomach, colon, lung, prostate, and liver [Supplemental Fig. 5 (a) and 5(b)]. In contrast, the AP2 motif, which was the second most overrepresented motif in our previous AR ChIP-seq study in mouse epididymis, was also most significantly enriched, second to the ERE, around the ERa-binding sites in mouse efferent ductules. Additionally, a recent report, which compared the genome-wide AR-binding sites in mouse kidney, prostate, and caput epididymis, further confirmed that the AP2 binding motif is exclusively enriched around the AR-binding sequences in the caput epididymis in a tissue-specific manner (55) . These results suggested that AP2 might play an essential role in the sex steroid hormone regulation of the proximal ductules of the male reproductive system. AR often colocalizes with ERa in many tissues and cell lines, which indicates the coregulation of target genes by these two sex steroid receptors. AR and ERa coexisted in the nucleus of mouse efferent ductules at high levels (56, 57) , and our real-time reverse transcription-PCR results of the E2 responsive solute carrier family genes indeed showed a diverse coregulatory mode by estrogen and androgen (Supplemental Fig. 6) . Previously, the direct interaction between AR and ERa was validated by the yeast and mammalian two-hybrid systems (43) , and the occupancy of the ERE by AR was also reported (58) . Recently, Need et al. (59) comprehensively investigated the gene expression profiling after treatment with E2 or DHT individually or simultaneously in the AR and ERa dual-positive luminal breast cancer cell line ZR-75-1 and compared the genome-wide receptor binding profiling of AR and ERa. They found that the regulation of 26% of the E2 and 15% of the DHT target genes was significantly affected by cotreatment with the other hormone. ChIP-seq also identified a substantial overlap between the two steroid receptor cistromes, with 10% to 13% of AR and ERa-binding sites located within 10 kb of the other receptor. Their results provide evidence of the coregulation of target genes by AR and ERa both at the transcriptome and cistrome. Our analysis of the ERa cistrome in mouse efferent ductules further illustrated that AR and ERa regulate target genes through diverse mechanisms. First, the unbiased identification of the transcription factor binding motifs within ERa-binding sites revealed that the AR cognate response element, GRE, was the third most overrepresented motif, indicating its coincidence with the ERE at a high frequency. Second, when we searched for transcription factor motifs within 10 to 50 bp away from the ERE motif within ERa-binding regions, GRE was the most overrepresented, which further confirmed the possibility that AR and ERa could cobind at a very close site to coregulate their target genes. Third, when the ERa-binding sites that were absent of a canonical ERE were submitted to MEME-ChIP for de novo motif discovery, the most significantly enriched sequence was very similar to the ARE half-site. Moreover, the direct interaction of AR and ERa in mouse efferent ductules, which was proved by co-IP, further directed us to hypothesize that AR might be involved in the tethering pathway of ERa as well. Fourth, the high frequency of the cobinding of AR and ERa to the same genomic loci was verified by ChIPqPCR for randomly selected ERa-binding regions and ERa-binding peaks of Slc9a3 gene. These results illustrated the broad interaction between AR and ERa.
In summary, our current study mapped the genomewide ERa-binding sites in mouse efferent ductules, whose function significantly relies on the existence of ERa protein. Although many ERa cistromes have been reported, all are from cancer cell lines or biopsies and female tissues. Our ERa ChIP-seq analysis in a male target tissue in physiological conditions expands our current knowledge of the ERa regulation mechanism, Appendix. Antibody Table   Peptide and it will be used as a reference set for future work aimed at exploring the mechanisms of action of ERa in pathological and physiological conditions.
